Variant report
Variant | esv2761402 |
---|---|
Chromosome Location | chr8:5864854-5873093 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10108017 | chr8:5864854-5864855 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs2703206 | chr8:5864890-5864891 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs2703207 | chr8:5864896-5864897 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs147459611 | chr8:5864917-5864918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148468965 | chr8:5864918-5864919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182875545 | chr8:5864926-5864927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1834201 | chr8:5864927-5864928 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs374897356 | chr8:5864948-5864949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2840409 | chr8:5864951-5864952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs116127431 | chr8:5864960-5864961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533792970 | chr8:5864990-5864991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141784460 | chr8:5865025-5865026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572363336 | chr8:5865041-5865042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs118054759 | chr8:5865060-5865061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2552253 | chr8:5865072-5865073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs116488031 | chr8:5865120-5865121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116007204 | chr8:5865125-5865126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551659538 | chr8:5865163-5865164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542182694 | chr8:5865164-5865165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74569969 | chr8:5865177-5865178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529282850 | chr8:5865178-5865179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116364082 | chr8:5865180-5865181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139559916 | chr8:5865231-5865232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2703208 | chr8:5865240-5865241 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs143403535 | chr8:5865299-5865300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186022192 | chr8:5865303-5865304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536781817 | chr8:5865381-5865382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372835768 | chr8:5865390-5865391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567197172 | chr8:5865433-5865434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534603826 | chr8:5865446-5865447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2703209 | chr8:5865460-5865461 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs572426543 | chr8:5865509-5865510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201896977 | chr8:5865527-5865528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34633303 | chr8:5865530-5865531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369263488 | chr8:5865547-5865548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190535052 | chr8:5865560-5865561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567783522 | chr8:5865620-5865621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146686067 | chr8:5865639-5865640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139211407 | chr8:5865649-5865650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34090429 | chr8:5865682-5865683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374967597 | chr8:5865687-5865688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs398112146 | chr8:5865690-5865691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374913183 | chr8:5865691-5865692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549208851 | chr8:5865698-5865699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183864127 | chr8:5865699-5865700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541421404 | chr8:5865727-5865728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188858021 | chr8:5865735-5865736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2703210 | chr8:5865771-5865772 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs2703211 | chr8:5865777-5865778 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs569895337 | chr8:5865779-5865780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5863000-5870200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:5865600-5866200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:5865600-5866200 | Enhancers | Fetal Heart | heart |
4 | chr8:5865600-5866200 | Enhancers | Hela-S3 | cervix |
5 | chr8:5865800-5866200 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr8:5865800-5866200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr8:5866000-5866200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr8:5866200-5875000 | Weak transcription | Hela-S3 | cervix |
9 | chr8:5866600-5869400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr8:5869400-5870400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr8:5870200-5870400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr8:5871200-5871600 | Enhancers | NHEK | skin |
13 | chr8:5871400-5871600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr8:5871600-5872200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr8:5871600-5875000 | Weak transcription | NHEK | skin |
16 | chr8:5872200-5872400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr8:5872400-5875000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr8:5872800-5874000 | Enhancers | Fetal Brain Male | brain |